Government Agencies SEC

More

  • The investor group, comprising six Chinese and one Pakistani citizen, is led by Libin Sun, who owns a 4.4 percent stake in the company, the filing with the Securities and Exchange Commission showed. The SEC could not be reached for comment. The Financial Industry Regulatory Authority declined to comment.

  • In a complaint filed in federal court in Manhattan, the SEC said Bassily, 50, routinely misled customers about their trading costs, and coached traders on the amount of hidden charges, known internally as "trading profits," they could collect without customers noticing. The SEC said the scheme ran from October 2006 until December 2011, and "directly enriched"...

  • Integrated Device Technology

    Shares of Integrated Device Technology soared 23 percent on more than triple the normal trading volume.

  • April 12- The U.S. Securities and Exchange Commission on Tuesday sued former ConvergEx Group executive Khaled "Kal" Bassily, accusing him of running a fraudulent scheme to regularly charge hidden mark-ups on customers' securities trades, on top of agreed-upon commissions. In a complaint filed in federal court in Manhattan, the SEC said the scheme led to millions...

  • Questions surround 'bid' for Integrated Device Tech

    CNBC's Eamon Javers provides perspective on the move higher in shares of Integrated Device Technology Inc. after the company disclosed information of a buyout bid by an investor group led by Libin Sun.

  • NEW YORK, April 12- Approval of a new regulatory standard related to the U.S. stock exchange application of startup trading platform IEX Group would prompt exchanges to create thousands of new order types and greatly complicate the market, the head of Nasdaq Inc said on Tuesday. The U.S. Securities and Exchange Commission said in a policy statement on March 18 it...

  • LONDON, April 12- Do you remember JPMorgan's Physical Copper Trust? Registered in October 2010 with the Securities and Exchange Commission, it was probably one of the most controversial commodity investment vehicles ever conceived. But by the time the SEC approved both products in late 2012, the investment tide had already turned.

  • WASHINGTON, April 6- The sole Republican member of the U.S. Securities and Exchange Commission, Michael Piwowar, expressed deep skepticism about a retirement advice rule that the Labor Department released on Wednesday, a sign of potential conflict over the long-awaited regulation. "I am disappointed that the rule announced today seems to ignore the chorus of...

  • "Whether the SEC will choose to make its own referral is left to that agency's discretion," Rakoff wrote. The SEC and Payton's lawyers declined comment. The SEC alleged that in 2009, an attorney at IBM Corp's law firm told his friend, Royal Bank of Scotland Group Plc analyst Trent Martin, that he was working on IBM's $1.2 billion acquisition of SPSS Inc..

  • SAN FRANCISCO, April 4- Nutanix on Monday disclosed a rise in quarterly revenues to a record high in a new regulatory filing that signaled the high-tech computing and storage company is proceeding with plans to go public. The U.S. Securities and Exchange Commission requires companies preparing an IPO to keep financial records up to date, so Nutanix's filing...

  • The company said it intends to file preliminary proxy materials with the U.S. Securities and Exchange Commission on Monday. Westlake said the total value of the revised proposal is about $3.1 billion, including $1.5 billion of Axiall's debt. Axiall shareholder Brigade Capital Management LP in February urged the company to consider selling itself and...

  • Mark Cuban, investor, entrepreneur and owner of the Dallas Mavericks

    Regulatory action on privately funded companies threatens to disrupt growth, Mark Cuban said.

  • Swisher: Tesla is a piece of history

    Re/code Executive Editor Kara Swisher talks about the demand for Tesla's new Model 3, the response to North Carolina's anti-LGBT law, as well as the head of the SEC's concern over unicorn companies.

  • March 31- The chair of the U.S. Securities and Exchange Commission took on "unicorns," tech startups and other privately held companies on Thursday, admonishing Silicon Valley firms to be fair and honest with their investors. "Being a private company comes with serious obligations to investors and the markets," Mary Jo White said in a speech at Stanford University...

  • The SEC also filed a related lawsuit accusing former Navistar Chief Executive Daniel Ustian of leading a "campaign of deception" to defraud investors in 2011 and 2012.. According to the SEC, Navistar spent more than $700 million to develop special "exhaust gas recirculation" technology to reduce nitrous oxide emissions, only to abandon the effort in July 2012...

  • G. Steven Burrill, 71, and his firm Burrill Capital Management LLC agreed to give up $4.785 million including interest that he siphoned for personal use, and pay a $1 million civil fine, the SEC said. The firm's former chief legal officer Victor Hebert, 78, and former controller Helena Sen, 62, agreed to pay respective $185,000 and $90,000 civil fines, the SEC said.

  • SEC settles case over allegedly stolen funds

    Biotech venture capitalist Steven Burrill has agreed to settle a case over alleged stolen funds, reports CNBC's Meg Tirrell.

  • The SEC said Smith and his investment research firm NBT Group Inc agreed in May 2012 to tout publicly traded IceWEB Inc, as part of a scheme by the data storage company's chief executive to inflate its trading volume and stock price. Smith and NBT did not fully disclose their compensation and incentive fees to investors, and made false and misleading statements...

  • March 29- Biotech company Aveo Pharmaceuticals Inc will pay $4 million to settle civil charges that it misled investors about U.S. regulators' concerns about its drug to treat kidney cancer, the Securities and Exchange Commission said on Tuesday. The company concealed the U.S. Food and Drug Administration's level of concern about the drug, Tivozanib, in public...

  • March 29- Biotech company Aveo Pharmaceuticals Inc will pay $4 million to settle civil charges that it misled investors about U.S. regulators' concerns involving its drug to treat kidney cancer, the Securities and Exchange Commission said on Tuesday. Aveo, in settling the case, neither admitted nor denied the SEC's allegations, the agency said.